Next Article in Journal
The Role of Non-Steroidal Anti-Inflammatory Drugs in Renal Colic
Next Article in Special Issue
Chemoprophylaxis of Tropical Infectious Diseases
Previous Article in Journal
Effects of NSAIDs on the Inner Ear: Possible Involvement in Cochlear Protection
Previous Article in Special Issue
Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(5), 1296-1303; doi:10.3390/ph3051296

The Treatment of Melioidosis

1
Division of Microbiology & Infectious Diseases, PathWest Laboratory Medicine WA, QEII Medical Centre, Nedlands, WA 6009, Australia
2
Microbiology & Immunology, School of Biomedical, Biomolecular and Chemical Sciences, Faculty of Life & Applied Sciences, University of Western Australia, Crawley, WA 6009, Australia
3
School of Pathology and Laboratory Medicine, Faculty of Medicine & Dentistry, University of Western Australia, Crawley, WA 6009, Australia
Received: 19 January 2010 / Revised: 29 March 2010 / Accepted: 20 April 2010 / Published: 27 April 2010
(This article belongs to the Special Issue Tropical Medicine)
View Full-Text   |   Download PDF [102 KB, uploaded 27 April 2010]

Abstract

Melioidosis is a complex bacterial infection, treatment of which combines the urgency of treating rapidly fatal Gram negative septicaemia with the need for eradication of long-term persistent disease in pulmonary, soft tissue, skeletal and other organ systems. Incremental improvements in treatment have been made as a result of multicentre collaboration across the main endemic region of Southeast Asia and northern Australia. There is an emerging consensus on the three main patterns of antimicrobial chemotherapy; initial (Phase 1) treatment, subsequent eradication (Phase 2) therapy and most recently post-exposure (Phase 0) prophylaxis. The combination of agents used, duration of therapy and need for adjunct modalities depends on the type, severity and antimicrobial susceptibility of infection. New antibiotic and adjunct therapies are at an investigational stage but on currently available data are unlikely to make a significant impact on this potentially fatal infection. View Full-Text
Keywords: melioidosis; treatment; antibiotics; adjunct therapy melioidosis; treatment; antibiotics; adjunct therapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Inglis, T.J. The Treatment of Melioidosis. Pharmaceuticals 2010, 3, 1296-1303.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top